Africa Cancer Leaders Institute

非洲癌症领袖研究所

• 批准号: 10754192
• 负责人: OLUFUNMILAYO F. OLOPADE
• 金额: $ 3万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-20 至 2026-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10754192
• 关键词: Advocacy; Africa; African; Area; Award; Clinical; Clinical Trials; Collaborations; Competence; Country; Development; Early identification; Education; Electronic Medical Records and Genomics Network; Emerging Technologies; Ethics; Evaluation; Faculty; Fostering; Foundations; Friends; Funding; Future; Generations; Genetic; Genomics; Goals; Grant; Income; Individual; Knowledge; Leadership; Learning; Location; Malignant Neoplasms; Mentors; Mentorship; Minority; Participant; Pathology; Persons; Policies; Portuguese; Productivity; Publications; Publishing; Records; Regional Cancer; Reporting; Research; Research Personnel; Research Training; Role; Senegal; Training; Translating; Travel; United States National Institutes of Health; Woman; aluminum sulfate; anticancer research; brain circulation; cancer therapy; career; career development; clinical development; cohort; design; experience; forging; improved; innovation; leadership development; lectures; meetings; member; novel strategies; outreach; peer; peer coaching; programs; recruit; research and development; symposium

PROJECT SUMMARY The proposed renewal application for African Cancer Leaders Institute (ACLI) is a “meeting within a meeting” designed to coincide with conferences organized by the African Organization for Research Training In Cancer (AORTIC) conference, beginning with the forthcoming, “Cancer in Africa: Implementation, Workforce, and Opportunities” in Dakar, Senegal, November 3-8, 2023.The ACLI will identify early career researchers, especially women and individuals underrepresented in global cancer research who are capable of leading interdisciplinary teams to improve cancer treatment in Africa. The long-term goal of the ACLI is to provide an intellectually stimulating platform to propel emerging global cancer leaders from Africa and the US to receive support for innovative cancer research in Africa, and to stimulate an African network for emerging leaders in cancer research. The ACLI platform will have annual goals and objectives set by the Education and Research Sub- Committees of AORTIC in collaboration with the ACLI program Organizers. The ACLI will widely solicit competitive applications from aspiring leaders in Africa and the US. During the past funding cycle, three cohorts of ACLI participants (60 total) were recruited and participated in AORTIC Conferences in Durban in 2017, Maputo in 2019 and Senegal in 2022 during a mini-retreat for ACLI members and AORTIC Council Members at the 1st African Regional Cancer Conference (ARCC) planned and hosted by AORTIC Leadership in West Africa. Awardees from all cohorts were invited to participate and 21 attended in person. It was gratifying to note enthusiastic participation by investigators from West Africa, especially those from French and Portuguese speaking countries. Most of the ARCC lectures were given by ACLI participants and researchers working in Africa who reported having received 6 NIH and 5 foundation grants. ACLI participants were unanimous in endorsing the need for a regional conference every other year that will provide greater capacity building opportunities and more succinct leadership programing for ACLI. For this renewal application, 10 Emerging Leaders will be fully-funded for travel to attend the AORTIC conference and participate in ACLI activities. Five emerging Leaders from high-income countries with meritorious abstracts and application will be selected for Merit travel award in order to continue to forge professional relationships and foster peer mentorship. ACLI participants will mostly network in groups of 6-8 with conversations on specific topics facilitated by Faculty and attend scientific sessions. For peer mentoring, sessions will be arranged for ACLI participants to discuss and evaluate concepts presented at the conference to enhance learning and career development experience. Each new ACLI participant will be asked to prepare a brief 15-minute overview of career accomplishments and plans for their career development activities. We will continue to track a number of metrics including conference evaluations, career landmarks, publication records and the number of ACLI members who compete successfully for Africa focused NIH/NCI grants e.g K43, K07, K23, R21 etc.

项目摘要 拟议的非洲癌症领导者研究所（ACLI）的续签申请是“会议中的会议” 旨在与非洲癌症研究培训组织组织的会议相吻合 （主动脉）会议，从即将到来的“非洲癌症：实施，劳动力和 2023年11月3日至8日在塞内加尔达喀尔的机会”。ACLI将确定早期的职业研究人员，尤其是 能够领导跨学科的全球癌症研究中的妇女和个人人数不足 改善非洲癌症治疗的团队。 ACLI的长期目标是在智力上提供 刺激平台推动来自非洲和美国的全球癌症领导者的支持 非洲的创新癌症研究，并刺激非洲网络，用于新兴的癌症领导者 研究。 ACLI平台将具有由教育和研究子制定的年度目标 主动脉委员会与ACLI计划组织者合作。 ACLI将广泛征集 非洲和美国有抱负的领导人的竞争应用。在过去的筹资周期中，三个队列 ACLI参与者（总共60名）被招募并参加2017年德班的主动脉会议 2019年和塞内加尔于2022年在ACLI成员和主动脉委员会成员的小型捕获期间 非洲区域癌症会议（ARCC）由西非主动脉领导计划和主持。 邀请所有队列的获奖者参加，并亲自参加21名。很高兴注意 来自西非的调查人员，特别是法国和葡萄牙人的调查人员的热情参与 说话国家。大多数ARCC讲座是由ACLI参与者和研究人员进行的 非洲报告已获得6份NIH和5个基金会补助金。 ACLI参与者一致 每隔一年就认可每隔一年的区域会议，以提供更大的能力建设 机遇和更简洁的领导力编程为ACLI。对于此续订应用程序，有10个新兴 领导者将获得全资金，参加参加主动脉会议并参加ACLI活动的旅行。 来自高收入国家的五个新兴领导人将有杰出的摘要和应用 被选为优异旅行奖，以便继续建立专业关系并培养同伴 精神制。 ACLI参与者将主要以6-8人群的形式进行有关特定主题的对话 由教师促进并参加科学会议。对于同伴的心理，将安排ACLI的会议 参与者讨论和评估会议上提出的概念以增强学习和职业 发展经验。每个新的ACLI参与者将被要求准备一个简短的15分钟概述 其职业发展活动的职业成就和计划。我们将继续跟踪许多 指标，包括会议评估，职业地标，出版记录和ACLI的数量 成功争夺非洲NIH/NCI赠款的成员，例如K43，K07，K23，R21等。